ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liver Cancer Diagnostic Tests Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-15B2208
Home | Market Reports | Health| Health Conditions| Cancer
Global Liver Cancer Diagnostic Tests Market Research Report 2020
BUY CHAPTERS

Global Liver Cancer Diagnostic Tests Market Research Report 2025

Code: QYRE-Auto-15B2208
Report
August 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Diagnostics
Abcodia
BioMark Technologies
AXO Science SAS
Bioprognos SL
China Sky One Medica
Digna Biotech SL
Glycotest

Liver Cancer Diagnostic Tests Market Size

The global market for Liver Cancer Diagnostic Tests was valued at US$ 8400 million in the year 2024 and is projected to reach a revised size of US$ 14470 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Liver Cancer Diagnostic Tests Market

Liver Cancer Diagnostic Tests Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liver Cancer Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Diagnostic Tests.
The Liver Cancer Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liver Cancer Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Cancer Diagnostic Tests manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Liver Cancer Diagnostic Tests Market Report

Report Metric Details
Report Name Liver Cancer Diagnostic Tests Market
Accounted market size in year US$ 8400 million
Forecasted market size in 2031 US$ 14470 million
CAGR 8.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott Diagnostics, Abcodia, BioMark Technologies, AXO Science SAS, Bioprognos SL, China Sky One Medica, Digna Biotech SL, Glycotest
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Liver Cancer Diagnostic Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Liver Cancer Diagnostic Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Liver Cancer Diagnostic Tests Market growing?

Ans: The Liver Cancer Diagnostic Tests Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Liver Cancer Diagnostic Tests Market size in 2031?

Ans: The Liver Cancer Diagnostic Tests Market size in 2031 will be US$ 14470 million.

Who are the main players in the Liver Cancer Diagnostic Tests Market report?

Ans: The main players in the Liver Cancer Diagnostic Tests Market are Abbott Diagnostics, Abcodia, BioMark Technologies, AXO Science SAS, Bioprognos SL, China Sky One Medica, Digna Biotech SL, Glycotest

What are the Application segmentation covered in the Liver Cancer Diagnostic Tests Market report?

Ans: The Applications covered in the Liver Cancer Diagnostic Tests Market report are Hospital, Physical Examination Center, Other

What are the Type segmentation covered in the Liver Cancer Diagnostic Tests Market report?

Ans: The Types covered in the Liver Cancer Diagnostic Tests Market report are Reagent, Instrument

Recommended Reports

Oncology Diagnostics

Liver & Hepatitis

Diagnostic Technologies

1 Liver Cancer Diagnostic Tests Market Overview
1.1 Product Definition
1.2 Liver Cancer Diagnostic Tests by Type
1.2.1 Global Liver Cancer Diagnostic Tests Market Value Comparison by Type (2024 VS 2031)
1.2.2 Reagent
1.2.3 Instrument
1.3 Liver Cancer Diagnostic Tests by Application
1.3.1 Global Liver Cancer Diagnostic Tests Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Physical Examination Center
1.3.4 Other
1.4 Global Liver Cancer Diagnostic Tests Market Size Estimates and Forecasts
1.4.1 Global Liver Cancer Diagnostic Tests Revenue 2020-2031
1.4.2 Global Liver Cancer Diagnostic Tests Sales 2020-2031
1.4.3 Global Liver Cancer Diagnostic Tests Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Liver Cancer Diagnostic Tests Market Competition by Manufacturers
2.1 Global Liver Cancer Diagnostic Tests Sales Market Share by Manufacturers (2020-2025)
2.2 Global Liver Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Liver Cancer Diagnostic Tests Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Liver Cancer Diagnostic Tests, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liver Cancer Diagnostic Tests, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liver Cancer Diagnostic Tests, Product Type & Application
2.7 Global Key Manufacturers of Liver Cancer Diagnostic Tests, Date of Enter into This Industry
2.8 Global Liver Cancer Diagnostic Tests Market Competitive Situation and Trends
2.8.1 Global Liver Cancer Diagnostic Tests Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Liver Cancer Diagnostic Tests Players Market Share by Revenue
2.8.3 Global Liver Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Liver Cancer Diagnostic Tests Market Scenario by Region
3.1 Global Liver Cancer Diagnostic Tests Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Liver Cancer Diagnostic Tests Sales by Region: 2020-2031
3.2.1 Global Liver Cancer Diagnostic Tests Sales by Region: 2020-2025
3.2.2 Global Liver Cancer Diagnostic Tests Sales by Region: 2026-2031
3.3 Global Liver Cancer Diagnostic Tests Revenue by Region: 2020-2031
3.3.1 Global Liver Cancer Diagnostic Tests Revenue by Region: 2020-2025
3.3.2 Global Liver Cancer Diagnostic Tests Revenue by Region: 2026-2031
3.4 North America Liver Cancer Diagnostic Tests Market Facts & Figures by Country
3.4.1 North America Liver Cancer Diagnostic Tests Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Liver Cancer Diagnostic Tests Sales by Country (2020-2031)
3.4.3 North America Liver Cancer Diagnostic Tests Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liver Cancer Diagnostic Tests Market Facts & Figures by Country
3.5.1 Europe Liver Cancer Diagnostic Tests Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Liver Cancer Diagnostic Tests Sales by Country (2020-2031)
3.5.3 Europe Liver Cancer Diagnostic Tests Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liver Cancer Diagnostic Tests Market Facts & Figures by Region
3.6.1 Asia Pacific Liver Cancer Diagnostic Tests Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Liver Cancer Diagnostic Tests Sales by Region (2020-2031)
3.6.3 Asia Pacific Liver Cancer Diagnostic Tests Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Liver Cancer Diagnostic Tests Market Facts & Figures by Country
3.7.1 Latin America Liver Cancer Diagnostic Tests Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Liver Cancer Diagnostic Tests Sales by Country (2020-2031)
3.7.3 Latin America Liver Cancer Diagnostic Tests Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liver Cancer Diagnostic Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa Liver Cancer Diagnostic Tests Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Liver Cancer Diagnostic Tests Sales by Country (2020-2031)
3.8.3 Middle East and Africa Liver Cancer Diagnostic Tests Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liver Cancer Diagnostic Tests Sales by Type (2020-2031)
4.1.1 Global Liver Cancer Diagnostic Tests Sales by Type (2020-2025)
4.1.2 Global Liver Cancer Diagnostic Tests Sales by Type (2026-2031)
4.1.3 Global Liver Cancer Diagnostic Tests Sales Market Share by Type (2020-2031)
4.2 Global Liver Cancer Diagnostic Tests Revenue by Type (2020-2031)
4.2.1 Global Liver Cancer Diagnostic Tests Revenue by Type (2020-2025)
4.2.2 Global Liver Cancer Diagnostic Tests Revenue by Type (2026-2031)
4.2.3 Global Liver Cancer Diagnostic Tests Revenue Market Share by Type (2020-2031)
4.3 Global Liver Cancer Diagnostic Tests Price by Type (2020-2031)
5 Segment by Application
5.1 Global Liver Cancer Diagnostic Tests Sales by Application (2020-2031)
5.1.1 Global Liver Cancer Diagnostic Tests Sales by Application (2020-2025)
5.1.2 Global Liver Cancer Diagnostic Tests Sales by Application (2026-2031)
5.1.3 Global Liver Cancer Diagnostic Tests Sales Market Share by Application (2020-2031)
5.2 Global Liver Cancer Diagnostic Tests Revenue by Application (2020-2031)
5.2.1 Global Liver Cancer Diagnostic Tests Revenue by Application (2020-2025)
5.2.2 Global Liver Cancer Diagnostic Tests Revenue by Application (2026-2031)
5.2.3 Global Liver Cancer Diagnostic Tests Revenue Market Share by Application (2020-2031)
5.3 Global Liver Cancer Diagnostic Tests Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott Diagnostics
6.1.1 Abbott Diagnostics Company Information
6.1.2 Abbott Diagnostics Description and Business Overview
6.1.3 Abbott Diagnostics Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Diagnostics Liver Cancer Diagnostic Tests Product Portfolio
6.1.5 Abbott Diagnostics Recent Developments/Updates
6.2 Abcodia
6.2.1 Abcodia Company Information
6.2.2 Abcodia Description and Business Overview
6.2.3 Abcodia Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abcodia Liver Cancer Diagnostic Tests Product Portfolio
6.2.5 Abcodia Recent Developments/Updates
6.3 BioMark Technologies
6.3.1 BioMark Technologies Company Information
6.3.2 BioMark Technologies Description and Business Overview
6.3.3 BioMark Technologies Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioMark Technologies Liver Cancer Diagnostic Tests Product Portfolio
6.3.5 BioMark Technologies Recent Developments/Updates
6.4 AXO Science SAS
6.4.1 AXO Science SAS Company Information
6.4.2 AXO Science SAS Description and Business Overview
6.4.3 AXO Science SAS Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AXO Science SAS Liver Cancer Diagnostic Tests Product Portfolio
6.4.5 AXO Science SAS Recent Developments/Updates
6.5 Bioprognos SL
6.5.1 Bioprognos SL Company Information
6.5.2 Bioprognos SL Description and Business Overview
6.5.3 Bioprognos SL Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bioprognos SL Liver Cancer Diagnostic Tests Product Portfolio
6.5.5 Bioprognos SL Recent Developments/Updates
6.6 China Sky One Medica
6.6.1 China Sky One Medica Company Information
6.6.2 China Sky One Medica Description and Business Overview
6.6.3 China Sky One Medica Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.6.4 China Sky One Medica Liver Cancer Diagnostic Tests Product Portfolio
6.6.5 China Sky One Medica Recent Developments/Updates
6.7 Digna Biotech SL
6.7.1 Digna Biotech SL Company Information
6.7.2 Digna Biotech SL Description and Business Overview
6.7.3 Digna Biotech SL Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Digna Biotech SL Liver Cancer Diagnostic Tests Product Portfolio
6.7.5 Digna Biotech SL Recent Developments/Updates
6.8 Glycotest
6.8.1 Glycotest Company Information
6.8.2 Glycotest Description and Business Overview
6.8.3 Glycotest Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Glycotest Liver Cancer Diagnostic Tests Product Portfolio
6.8.5 Glycotest Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liver Cancer Diagnostic Tests Industry Chain Analysis
7.2 Liver Cancer Diagnostic Tests Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liver Cancer Diagnostic Tests Production Mode & Process Analysis
7.4 Liver Cancer Diagnostic Tests Sales and Marketing
7.4.1 Liver Cancer Diagnostic Tests Sales Channels
7.4.2 Liver Cancer Diagnostic Tests Distributors
7.5 Liver Cancer Diagnostic Tests Customer Analysis
8 Liver Cancer Diagnostic Tests Market Dynamics
8.1 Liver Cancer Diagnostic Tests Industry Trends
8.2 Liver Cancer Diagnostic Tests Market Drivers
8.3 Liver Cancer Diagnostic Tests Market Challenges
8.4 Liver Cancer Diagnostic Tests Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott Diagnostics
Abcodia
BioMark Technologies
AXO Science SAS
Bioprognos SL
China Sky One Medica
Digna Biotech SL
Glycotest
List of Tables
 Table 1. Global Liver Cancer Diagnostic Tests Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Liver Cancer Diagnostic Tests Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Liver Cancer Diagnostic Tests Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Liver Cancer Diagnostic Tests Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Liver Cancer Diagnostic Tests Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Liver Cancer Diagnostic Tests Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Liver Cancer Diagnostic Tests Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Liver Cancer Diagnostic Tests Average Price (K USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Liver Cancer Diagnostic Tests, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Liver Cancer Diagnostic Tests, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Liver Cancer Diagnostic Tests, Product Type & Application
 Table 12. Global Key Manufacturers of Liver Cancer Diagnostic Tests, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Liver Cancer Diagnostic Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Diagnostic Tests as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Liver Cancer Diagnostic Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Liver Cancer Diagnostic Tests Sales by Region (2020-2025) & (Units)
 Table 18. Global Liver Cancer Diagnostic Tests Sales Market Share by Region (2020-2025)
 Table 19. Global Liver Cancer Diagnostic Tests Sales by Region (2026-2031) & (Units)
 Table 20. Global Liver Cancer Diagnostic Tests Sales Market Share by Region (2026-2031)
 Table 21. Global Liver Cancer Diagnostic Tests Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Liver Cancer Diagnostic Tests Revenue Market Share by Region (2020-2025)
 Table 23. Global Liver Cancer Diagnostic Tests Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Liver Cancer Diagnostic Tests Revenue Market Share by Region (2026-2031)
 Table 25. North America Liver Cancer Diagnostic Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Liver Cancer Diagnostic Tests Sales by Country (2020-2025) & (Units)
 Table 27. North America Liver Cancer Diagnostic Tests Sales by Country (2026-2031) & (Units)
 Table 28. North America Liver Cancer Diagnostic Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Liver Cancer Diagnostic Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Liver Cancer Diagnostic Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Liver Cancer Diagnostic Tests Sales by Country (2020-2025) & (Units)
 Table 32. Europe Liver Cancer Diagnostic Tests Sales by Country (2026-2031) & (Units)
 Table 33. Europe Liver Cancer Diagnostic Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Liver Cancer Diagnostic Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Liver Cancer Diagnostic Tests Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Liver Cancer Diagnostic Tests Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Liver Cancer Diagnostic Tests Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Liver Cancer Diagnostic Tests Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Liver Cancer Diagnostic Tests Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Liver Cancer Diagnostic Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Liver Cancer Diagnostic Tests Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Liver Cancer Diagnostic Tests Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Liver Cancer Diagnostic Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Liver Cancer Diagnostic Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Liver Cancer Diagnostic Tests Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Liver Cancer Diagnostic Tests Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Liver Cancer Diagnostic Tests Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Liver Cancer Diagnostic Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Liver Cancer Diagnostic Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Liver Cancer Diagnostic Tests Sales (Units) by Type (2020-2025)
 Table 51. Global Liver Cancer Diagnostic Tests Sales (Units) by Type (2026-2031)
 Table 52. Global Liver Cancer Diagnostic Tests Sales Market Share by Type (2020-2025)
 Table 53. Global Liver Cancer Diagnostic Tests Sales Market Share by Type (2026-2031)
 Table 54. Global Liver Cancer Diagnostic Tests Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Liver Cancer Diagnostic Tests Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Liver Cancer Diagnostic Tests Revenue Market Share by Type (2020-2025)
 Table 57. Global Liver Cancer Diagnostic Tests Revenue Market Share by Type (2026-2031)
 Table 58. Global Liver Cancer Diagnostic Tests Price (K USD/Unit) by Type (2020-2025)
 Table 59. Global Liver Cancer Diagnostic Tests Price (K USD/Unit) by Type (2026-2031)
 Table 60. Global Liver Cancer Diagnostic Tests Sales (Units) by Application (2020-2025)
 Table 61. Global Liver Cancer Diagnostic Tests Sales (Units) by Application (2026-2031)
 Table 62. Global Liver Cancer Diagnostic Tests Sales Market Share by Application (2020-2025)
 Table 63. Global Liver Cancer Diagnostic Tests Sales Market Share by Application (2026-2031)
 Table 64. Global Liver Cancer Diagnostic Tests Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Liver Cancer Diagnostic Tests Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Liver Cancer Diagnostic Tests Revenue Market Share by Application (2020-2025)
 Table 67. Global Liver Cancer Diagnostic Tests Revenue Market Share by Application (2026-2031)
 Table 68. Global Liver Cancer Diagnostic Tests Price (K USD/Unit) by Application (2020-2025)
 Table 69. Global Liver Cancer Diagnostic Tests Price (K USD/Unit) by Application (2026-2031)
 Table 70. Abbott Diagnostics Company Information
 Table 71. Abbott Diagnostics Description and Business Overview
 Table 72. Abbott Diagnostics Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Diagnostics Liver Cancer Diagnostic Tests Product
 Table 74. Abbott Diagnostics Recent Developments/Updates
 Table 75. Abcodia Company Information
 Table 76. Abcodia Description and Business Overview
 Table 77. Abcodia Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 78. Abcodia Liver Cancer Diagnostic Tests Product
 Table 79. Abcodia Recent Developments/Updates
 Table 80. BioMark Technologies Company Information
 Table 81. BioMark Technologies Description and Business Overview
 Table 82. BioMark Technologies Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 83. BioMark Technologies Liver Cancer Diagnostic Tests Product
 Table 84. BioMark Technologies Recent Developments/Updates
 Table 85. AXO Science SAS Company Information
 Table 86. AXO Science SAS Description and Business Overview
 Table 87. AXO Science SAS Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 88. AXO Science SAS Liver Cancer Diagnostic Tests Product
 Table 89. AXO Science SAS Recent Developments/Updates
 Table 90. Bioprognos SL Company Information
 Table 91. Bioprognos SL Description and Business Overview
 Table 92. Bioprognos SL Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 93. Bioprognos SL Liver Cancer Diagnostic Tests Product
 Table 94. Bioprognos SL Recent Developments/Updates
 Table 95. China Sky One Medica Company Information
 Table 96. China Sky One Medica Description and Business Overview
 Table 97. China Sky One Medica Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 98. China Sky One Medica Liver Cancer Diagnostic Tests Product
 Table 99. China Sky One Medica Recent Developments/Updates
 Table 100. Digna Biotech SL Company Information
 Table 101. Digna Biotech SL Description and Business Overview
 Table 102. Digna Biotech SL Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 103. Digna Biotech SL Liver Cancer Diagnostic Tests Product
 Table 104. Digna Biotech SL Recent Developments/Updates
 Table 105. Glycotest Company Information
 Table 106. Glycotest Description and Business Overview
 Table 107. Glycotest Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 108. Glycotest Liver Cancer Diagnostic Tests Product
 Table 109. Glycotest Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Liver Cancer Diagnostic Tests Distributors List
 Table 113. Liver Cancer Diagnostic Tests Customers List
 Table 114. Liver Cancer Diagnostic Tests Market Trends
 Table 115. Liver Cancer Diagnostic Tests Market Drivers
 Table 116. Liver Cancer Diagnostic Tests Market Challenges
 Table 117. Liver Cancer Diagnostic Tests Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Liver Cancer Diagnostic Tests
 Figure 2. Global Liver Cancer Diagnostic Tests Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liver Cancer Diagnostic Tests Market Share by Type: 2024 & 2031
 Figure 4. Reagent Product Picture
 Figure 5. Instrument Product Picture
 Figure 6. Global Liver Cancer Diagnostic Tests Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Liver Cancer Diagnostic Tests Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Physical Examination Center
 Figure 10. Other
 Figure 11. Global Liver Cancer Diagnostic Tests Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Liver Cancer Diagnostic Tests Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Liver Cancer Diagnostic Tests Sales (2020-2031) & (Units)
 Figure 14. Global Liver Cancer Diagnostic Tests Average Price (K USD/Unit) & (2020-2031)
 Figure 15. Liver Cancer Diagnostic Tests Report Years Considered
 Figure 16. Liver Cancer Diagnostic Tests Sales Share by Manufacturers in 2024
 Figure 17. Global Liver Cancer Diagnostic Tests Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Liver Cancer Diagnostic Tests Players: Market Share by Revenue in Liver Cancer Diagnostic Tests in 2024
 Figure 19. Liver Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Liver Cancer Diagnostic Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Liver Cancer Diagnostic Tests Sales Market Share by Country (2020-2031)
 Figure 22. North America Liver Cancer Diagnostic Tests Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Liver Cancer Diagnostic Tests Sales Market Share by Country (2020-2031)
 Figure 26. Europe Liver Cancer Diagnostic Tests Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Liver Cancer Diagnostic Tests Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Liver Cancer Diagnostic Tests Revenue Market Share by Region (2020-2031)
 Figure 34. China Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Liver Cancer Diagnostic Tests Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Liver Cancer Diagnostic Tests Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Liver Cancer Diagnostic Tests Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Liver Cancer Diagnostic Tests Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Liver Cancer Diagnostic Tests Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Liver Cancer Diagnostic Tests by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Liver Cancer Diagnostic Tests by Type (2020-2031)
 Figure 56. Global Liver Cancer Diagnostic Tests Price (K USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Liver Cancer Diagnostic Tests by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Liver Cancer Diagnostic Tests by Application (2020-2031)
 Figure 59. Global Liver Cancer Diagnostic Tests Price (K USD/Unit) by Application (2020-2031)
 Figure 60. Liver Cancer Diagnostic Tests Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024
Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Global Liver Cancer Treatment Drug Market Research Report 2025
Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Electro Diagnostic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Fetal Monitoring and Diagnostics Test Market Research Report 2024
Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Automated Clinical Diagnostic System Market Research Report 2024
Liver Diseases Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lateral Flow Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Point of Care Diagnostic and Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High throughput Drug Screening Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions